CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 92 filers reported holding CUE BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is 4.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 16 | -99.9% | 0.00% | – |
| Q1 2022 | $108,000 | -53.4% | 22,053 | +7.2% | 0.00% | – |
| Q4 2021 | $232,000 | -0.4% | 20,580 | +28.8% | 0.00% | – |
| Q3 2021 | $233,000 | -7.5% | 15,981 | -26.1% | 0.00% | – |
| Q2 2021 | $252,000 | -10.0% | 21,628 | -5.7% | 0.00% | – |
| Q1 2021 | $280,000 | -59.7% | 22,943 | -58.6% | 0.00% | – |
| Q4 2020 | $694,000 | -21.3% | 55,459 | -5.4% | 0.00% | -100.0% |
| Q3 2020 | $882,000 | -32.4% | 58,617 | +10.1% | 0.00% | 0.0% |
| Q2 2020 | $1,305,000 | – | 53,240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 820,000 | $11,636,000 | 12.56% |
| Prosight Management, LP | 552,060 | $7,834,000 | 3.66% |
| Nantahala Capital Management | 2,503,840 | $35,529,000 | 1.33% |
| MANGROVE PARTNERS IM, LLC | 601,398 | $8,534,000 | 1.18% |
| Voss Capital, LLC | 88,670 | $749,000 | 1.00% |
| Slate Path Capital LP | 870,694 | $12,355,000 | 0.95% |
| Avoro Capital Advisors LLC | 1,870,000 | $26,535,000 | 0.90% |
| Bleichroeder LP | 165,000 | $2,341,000 | 0.61% |
| 683 Capital Management, LLC | 640,000 | $9,082,000 | 0.54% |
| PA Capital LLC | 40,706 | $578,000 | 0.51% |